Awareness and understanding about T1D in Australia is low, particularly for adults living with the chronic condition.
Life-saving and life-changing technologies to measure blood glucose and deliver insulin in response to need are the foundation of type 1 diabetes (T1D) treatment and care in the 21st century. But in Australia, access to these technologies is inconsistent, inequitable, and incomplete. Even worse, they cut out for many on adulthood. This needs to change. […]
Mr Narev will bring more than 30 years of strategy and leadership experience garnered across consulting finance and technology businesses. JDRF Australia are delighted to welcome Ian Narev, Managing Director and Chief Executive Officer of SEEK to the Board. Mr Narev, who joined the Board at the September 2021 Board meeting, is no stranger to JDRF having spent several years as co-Chair of the JDRF Australia Advisory Board. Alongside his historical […]
Let’s meet the inspiring father-daughter duo who share a passion for BMX riding and a goal to help defeat type 1 diabetes. Daniel was diagnosed with type 1 diabetes (T1D) at a young age, but that didn’t stop him from becoming a proud father of two, a motorcycle racer, and a mentor and supporter to […]
UPDATED September 2022 Australia has rolled out two COVID-19 vaccines – one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines now being offered to people with T1D, we’ve gathered all the information you need to […]
The Medtronic Minimed 770G will be added to the Federal Governments Insulin Pump Program – a significant step toward achieving our goal of more technology for more people through our policy agenda. So, what does this mean for you?
Australians living with type 1 diabetes (T1D) are disproportionately affected by a psychological phenomenon called decision fatigue, which hinders their ability to make vital decisions – placing them at greater risk of life-threatening complications such as heart attack and kidney disease.1 People living with T1D must make an extra 180 decisions every day compared to […]
First report of its kind in a decade shows the incidence of type 1 diabetes (T1D) in Australia has grown to more than 125,000 people today, with the economic cost now standing at a staggering $2.9 billion per year. The report also highlights the significant financial impact of complications of the disease, with the presence of just two complications increasing the cost to the economy more than fourfold. There is also a serious mental health impact of living with T1D, with patients five times […]
For the past 100 years, the only effective treatment for type 1 diabetes (T1D) has been insulin. For the more than 125,000 Australians living with T1D insulin is a lifesaving medication that regulates the amount of sugar in the bloodstream. Insulin is something that people who don’t live with T1D produce naturally. Outside of the lifelong regimen of insulin infusions and blood sugar checks, people with T1D are more likely to […]
For the more than 125,000 Australians that live with type 1 diabetes (T1D) – insulin is more than a lifechanging treatment. It’s a lifesaving one. A substance made naturally in the body for those who don’t live with diabetes, insulin regulates the amount of sugar in the blood – something that can change depending on […]
Each year, JDRF offers a PhD Top-Up Scholarship to provide additional funding for PhD students pursuing type 1 diabetes research. Since its inception, the scholarship has helped more than 20 outstanding students kick-start a career in T1D research. Over the next few weeks, we’re catching up with some former recipients to find out what they’ve […]
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]
Results from a recently completed JDRF clinical trial have shown some big benefits to hybrid closed-loop technology. Published in the journal Diabetes Care, the results come from a trial led by Prof David O’Neal from the University of Melbourne and the Australian JDRF Closed-Loop Research Group. This study was funded by JDRF through its Type […]
Living with type 1 diabetes, pizza is probably one of your favourite meals on takeaway night. But it can also be the most challenging. In fact, you might often approach such a delicious meal with a little trepidation, anticipating how it can make managing your BGLs difficult. People living with type 1 diabetes often report […]